Form 8-K - Current report:
SEC Accession No. 0001437749-20-020264
Filing Date
2020-09-25
Accepted
2020-09-25 16:57:21
Documents
4
Period of Report
2020-09-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dffn20200925_8k.htm 8-K 36071
2 EXHIBIT 10.1 ex_205132.htm EX-10.1 123598
3 EXHIBIT 99.1 ex_205133.htm EX-99.1 15073
4 logo02.gif GRAPHIC 4839
  Complete submission text file 0001437749-20-020264.txt   183151
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37942 | Film No.: 201200778
SIC: 2834 Pharmaceutical Preparations